56 results match your criteria: "School of Preventive Oncology[Affiliation]"
JAMA Oncol
October 2023
Department of Preventive and Social Dentistry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Prev Med Rep
October 2023
PGIMER, Chandigarh, India.
Ecancermedicalscience
February 2023
Department of Clinical Oncology, Indian Council of Medical Research - National Institute of Cancer Prevention and Research (ICMR-NICPR), Noida 201301, India.
Introduction: This article elicits our experiences and strategic approaches to ensure the sustainability of the online capacity-building programmes for healthcare providers (HCPs) in comprehensive cancer screening through the 'Hub and Spoke' model during the coronavirus disease (COVID-19) pandemic.
Methods: During the first wave of COVID-19, training for three cohorts of medical officers (MO) (Batch-A) was ongoing (May-December 2020). The Indian health system abruptly shifted focus towards containing the COVID-19 spread, leading to new challenges in conducting training courses.
Indian J Dent Res
January 2023
Division of Clinical Oncology, Indian Council of Medical Research - National Institute of Cancer Prevention & Research (ICMR-NICPR), Noida, Uttar Pradesh, India.
Context: Oral cancer is the third common cancer in India. Its mortality can be reduced through early detection and tobacco cessation ideally by dentists owing to their forte of work.
Aim: This study was conducted to discuss effectiveness of an advanced tele-mentoring programme in oral cancer screening and tobacco cessation for dentists across India.
N Engl J Med
November 2022
From the International Agency for Research on Cancer (V.B., S.T.N., D.S., R.S., B.L.-S.), and INSERM 1052, Centre National de la Recherche Scientifique 5286, Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, and the Department of Medical Oncology, Centre Léon Bérard (P.S.) - all in Lyon, France; the Collaborating Centre for Oral Cancer of the World Health Organization (WHO) (S.W.) and the Faculty of Dentistry, Oral, and Craniofacial Sciences (N.W.J.), King's College London, London, the University of Sheffield School of Health and Related Research, Sheffield (O.M.), and the School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow (D.I.C.) - all in the United Kingdom; Center for Health, Innovation, and Policy Foundation and Rollins School of Public Health, Emory University, Atlanta (R.M.); the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (A.K.C.); the Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei (T.H.-H.C.); Sefako Makgatho Health Sciences University, Ga-Rankuwa, and the School of Health Systems and Public Health, University of Pretoria, Pretoria - both in South Africa (O.A.A.-Y.); Healis Sekhsaria Institute for Public Health (P.C.G.) and Preventive Oncology, Karkinos Healthcare (R.S.), Navi Mumbai, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram (D.A.), Regional Cancer Centre, Trivandrum (K.R.), and the School of Preventive Oncology, Patna (D.N.S.) - all in India; New York University College of Dentistry, New York (A.R.K.); University of Peradeniya, Peradeniya, Sri Lanka (W.M.T.); the Faculty of Dentistry, University of Malaya, Kuala Lumpur (W.M.T., R.B.Z.), and MAHSA (Malaysian Allied Health Sciences Academy) University, Bandar Saujana Putra (R.B.Z.) - both in Malaysia; M.D. Anderson Cancer Center, Houston (A.G.); Griffith University Gold Coast, Southport, QLD, Australia (N.W.J.); University of São Paulo Medical School and A.C. Camargo Cancer Center (L.P.K.), São Paulo, and Piracicaba Dental School, University of Campinas, Campinas (A.R.S.-S.) - all in Brazil; the Department of Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nisshin, Japan (T.N.); WHO, Geneva (V.M.P., F.R.); and the Department of Otorhinolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand (P.V.).
EClinicalMedicine
November 2022
Division of Preventive Oncology & Population Health, WHO FCTC Knowledge Hub on Smokeless Tobacco, ICMR-National Institute of Cancer Prevention and Research, Noida, India.
Cancer Prev Res (Phila)
November 2022
Centre for Health, Innovation and Policy, Noida, Gautam Budh Nagar, Uttar Pradesh, India.
Unlabelled: Smokeless tobacco (SLT) use is a significant cause of lip and oral cavity cancers. Globally, oral cancer prevalence is strongly linked to the types of tobacco products used, their chemical composition, and their pattern of use. Except snus, all SLT products sold in different World Health Organization regions are strongly associated with oral cancer incidence.
View Article and Find Full Text PDFBackground: Areca nut (AN) is a proven human carcinogen and a global public health menace. There is yet no review providing comprehensive information on the determinants and interventions available for cessation of AN. This systematic review was aimed at summarizing the available literature on drivers and interventions for cessation of AN chewing habit and to highlight the research lacunae.
View Article and Find Full Text PDFAnn Glob Health
May 2022
ISGlobal, Barcelona, Spain, and Boston College, Chestnut Hill, MA, USA.
Background: Areca nut (AN), the principal ingredient of betel quid (BQ) has been categorized as a human carcinogen associated with various cancers of upper aerodigestive tract. However, there has been no attempt at summarizing the risk reversal of oral and other cancers after cessation of BQ with or without tobacco (BQ+T/BQ-T).
Objective: To analyze the effect of cessation of betel quid without tobacco (BQ-T) and with tobacco (BQ+T) on reversal of the risk of oral, pharyngeal and oesophageal cancers.
JAMA Netw Open
January 2022
Division of Health Sciences, University of Warwick, Coventry, United Kingdom.
Importance: Visual screening for oral cancer has been found to be useful in a large randomized clinical trial in Kerala, India, showing substantial reduction in mortality. To address the shortage of medical personnel in resource-deficient regions, using the services of community health workers has been proposed as a strategy to fill the gap in human resources in health care.
Objective: To assess the feasibility of community health workers in screening and early detection of oral cancer using a mobile application capturing system.
Ecancermedicalscience
May 2021
Chief Executive Officer, ICMR - India Cancer Research Consortium, IRCS Building, Red Cross Road, Delhi 110003, India.
Background: Tobacco consumption in India varies based on the place of residence (urban/rural). Minimal, exclusive information exists regarding the same for 'urban slum' dwellers. The current study determines the tobacco use pattern among such individuals in Noida, Uttar Pradesh (India).
View Article and Find Full Text PDFBMJ Open
June 2021
WHO FCTC Global Knowledge Hub on Smokeless Tobacco, ICMR - National Institute of Cancer Prevention and Research, Noida, India.
Objective: Areca nut is one of the most widely consumed substances globally, after nicotine, ethanol and caffeine and classified as carcinogenic to humans. This study examines the disparity and determinants of areca nut consumption with and without tobacco in India.
Design: Nationally representative cross-sectional study.
Tob Use Insights
September 2020
School of Preventive Oncology, Patna, India.
Background: Worldwide, tobacco use is a serious public health concern affecting the youth. A vast majority of tobacco users start using tobacco well before the age of 18 years which has enormous psychosocial and health effects.
Objectives: To estimate the prevalence of individual forms of tobacco usage among youth aged 15 to 24 years and to assess the association of sociodemographic factors with tobacco use.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria.
Methods: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation.
Tob Prev Cessat
May 2020
Ministry of Health and Family Welfare, Government of India, New Delhi, India.
Introduction: Bidis are the most commonly smoked tobacco product in India. Understanding bidi smoking is important to reducing overall tobacco smoking and health-related consequences in India. We analyzed 2009-2010 and 2016-2017 Global Adult Tobacco Survey (GATS) India data to examine bidi smoking and its associated sociodemographic correlates and perceptions of dangers of smoking.
View Article and Find Full Text PDFJ Public Health (Oxf)
April 2021
ICMR-National Institute for Cancer Prevention and Research and Director, WHO FCTC Global Knowledge Hub on Smokeless Tobacco, I-7, Sector-39, Noida (U.P), India.
BMJ Glob Health
July 2020
India Cancer Research Consortium, New Delhi, Delhi, India.
We examined the magnitude of smokeless tobacco (SLT) use in India and identified policy gaps to ascertain the priorities for SLT control in India and other high SLT burden countries in the Southeast Asia region. We reviewed and analysed the legal and policy framework to identify policy gaps, options and priority areas to address the SLT burden in India and lessons thereof. In India, 21.
View Article and Find Full Text PDFInj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Nicotine Tob Res
December 2020
Indian Cancer Research Consortium, Indian Council of Medical Research, New Delhi, India.
Introduction: The dual use of smoked and smokeless tobacco (SLT) poses a serious challenge to tobacco control efforts. This article examines the trends and patterns of this usage in India during the period 2009-2010 and 2016-2017.
Methods: Data from two rounds of nationally representative cross-sectional Global Adult Tobacco Survey (GATS) conducted in 2009-2010 and 2016-2017 have been used.
Inj Prev
October 2020
Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
Regul Toxicol Pharmacol
February 2020
ICMR- India Cancer Research Consortium, Department of Health Research (Govt. of India), 1- Red Cross Road, New Delhi, 110001, India. Electronic address:
Areca Nut (AN), the seed of tropical palm tree Areca catechu, is a widely chewed natural product with estimated 600 million users across the world. Various AN products, thriving in the market, portray 'Areca nut' or 'Supari' as mouth freshener and safe alternative to smokeless tobacco. Unfortunately, AN is identified as a Group 1 human carcinogen by International Agency for Research on Cancer (IARC).
View Article and Find Full Text PDFNature
October 2019
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Since 2000, many countries have achieved considerable success in improving child survival, but localized progress remains unclear. To inform efforts towards United Nations Sustainable Development Goal 3.2-to end preventable child deaths by 2030-we need consistently estimated data at the subnational level regarding child mortality rates and trends.
View Article and Find Full Text PDFNicotine Tob Res
April 2020
ICMR-National Institute of Cancer Prevention and Research (NICPR), Noida, Uttar Pradesh, India.
Introduction: Consumption of smokeless tobacco (SLT) is on the rise (especially in the World Health Organization South-East Asian region) and has numerous repercussions over the consumer's health. This article reviews studies performed for SLT cessation using behavioral interventions, worldwide till 2017.
Methods: A systematic review by PICO (Problem, intervention, comparison, outcome) of behavioral intervention-based SLT cessation studies with minimum 6 months' follow-up, reporting outcomes in terms of risk ratios (RRs) and 95% confidence interval (CI), published between 1992 and 2017 was performed.
J Public Health (Oxf)
May 2020
ICMR-National Institute for Cancer Prevention and Research and Director, WHO FCTC Global Knowledge Hub on Smokeless Tobacco, I-7, Sector-39, Noida (U.P), India.
Background: The association of smokeless tobacco (SLT) with stroke has been dealt with in only a few reviews. The present meta-analysis aims to present the updated comprehensive summary risk of stroke in adult SLT users along with sub group analysis.
Methods: A systematic literature search for articles evaluating risk of stroke in SLT users was conducted.
Lancet Oncol
April 2019
Healis-Sekhsaria Institute for Public Health, Navi Mumbai, Maharashtra, India.
Smokeless tobacco is consumed by 356 million people globally and is a leading cause of head and neck cancers. However, global efforts to control smokeless tobacco use trail behind the progress made in curbing cigarette consumption. In this Policy Review, we describe the extent of the policy implementation gap in smokeless tobacco control, discuss key reasons on why it exists, and make recommendations on how to bridge this gap.
View Article and Find Full Text PDF